Griffith M J, Breitkreutz L, Trapp H, Briet E, Noyes C M, Lundblad R L, Roberts H R
J Clin Invest. 1985 Jan;75(1):4-10. doi: 10.1172/JCI111694.
Two structurally different forms of activated human Factor IX (Factor IXa alpha and IXa beta) have been previously reported to have essentially identical clotting activity in vitro. Although it has been shown that activated Factor IX Chapel Hill, an abnormal Factor IX isolated from the plasma of a patient with mild hemophilia B, and normal Factor IXa alpha are structurally very similar, the clotting activity of activated Factor IX Chapel Hill is much lower (approximately fivefold) than that of normal Factor IXa beta. In the present study we have prepared activated Factor IX by incubating human Factor IX with calcium and Russell's viper venom covalently bound to agarose. Fractionation of the activated Factor IX by high-performance liquid chromatography demonstrated the presence of both Factors IXa alpha and IXa beta. On the basis of active site concentration, determined by titration with antithrombin III, the clotting activities of activated Factor IX Chapel Hill and IXa alpha were similar, but both activities were less than 20% of the clotting activity of Factor IXa beta. Activated Factor IX activity was also measured in the absence of calcium, phospholipid, and Factor VIII, by determination of the rate of Factor X activation in the presence of polylysine. In the presence of polylysine, the rates of Factor X activation by activated Factor IX Chapel Hill, Factor IXa alpha, and Factor IXa beta were essentially identical. We conclude that the clotting activity of activated Factor IX Chapel Hill is reduced when compared with that of Factor IXa beta but essentially normal when compared with that of Factor IXa alpha.
先前有报道称,两种结构不同的活化人凝血因子IX(因子IXaα和IXaβ)在体外具有基本相同的凝血活性。尽管已表明,从一名轻度B型血友病患者血浆中分离出的异常凝血因子IX——活化凝血因子IX查珀尔希尔,与正常的因子IXaα在结构上非常相似,但活化凝血因子IX查珀尔希尔的凝血活性比正常的因子IXaβ低得多(约为五分之一)。在本研究中,我们通过将人凝血因子IX与共价结合到琼脂糖上的钙和罗素蝰蛇毒一起孵育来制备活化凝血因子IX。通过高效液相色谱对活化凝血因子IX进行分级分离,结果表明同时存在因子IXaα和IXaβ。根据用抗凝血酶III滴定测定的活性位点浓度,活化凝血因子IX查珀尔希尔和IXaα的凝血活性相似,但两者的活性均小于因子IXaβ凝血活性的20%。在不存在钙、磷脂和因子VIII的情况下,通过测定在聚赖氨酸存在下因子X激活的速率,也对活化凝血因子IX活性进行了测量。在聚赖氨酸存在下,活化凝血因子IX查珀尔希尔、因子IXaα和因子IXaβ激活因子X的速率基本相同。我们得出结论,与因子IXaβ相比,活化凝血因子IX查珀尔希尔的凝血活性降低,但与因子IXaα相比基本正常。